IL147575A - Method for purifying keratinocyte growth factors - Google Patents

Method for purifying keratinocyte growth factors

Info

Publication number: IL147575A
Authority: IL; Israel
Prior art keywords: kgf; seq; solution; oxidized; cation exchange
Prior art date: 1994-10-13

Application number

IL14757595A

Other languages

English (en)

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-10-12

Publication date

2004-05-12

1995-06-07 Priority claimed from US08/487,830 external-priority patent/US6008328A/en

1995-10-12 Application filed by Amgen Inc filed Critical Amgen Inc

2004-05-12 Publication of IL147575A publication Critical patent/IL147575A/en

Links

238000000034 method Methods 0.000 title claims description 71
239000003102 growth factor Substances 0.000 title abstract description 13
210000002510 keratinocyte Anatomy 0.000 title abstract description 12
108090000385 Fibroblast growth factor 7 Proteins 0.000 claims description 141
102000003972 Fibroblast growth factor 7 Human genes 0.000 claims description 133
210000004027 cell Anatomy 0.000 claims description 37
150000001413 amino acids Chemical group 0.000 claims description 26
238000004191 hydrophobic interaction chromatography Methods 0.000 claims description 22
239000011347 resin Substances 0.000 claims description 19
229920005989 resin Polymers 0.000 claims description 19
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 18
239000003729 cation exchange resin Substances 0.000 claims description 18
239000007800 oxidant agent Substances 0.000 claims description 16
229920000936 Agarose Polymers 0.000 claims description 15
239000012504 chromatography matrix Substances 0.000 claims description 15
238000011068 loading method Methods 0.000 claims description 12
NGDIAZZSCVVCEW-UHFFFAOYSA-M sodium;butyl sulfate Chemical compound [Na+].CCCCOS([O-])(=O)=O NGDIAZZSCVVCEW-UHFFFAOYSA-M 0.000 claims description 10
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 8
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
108010053070 Glutathione Disulfide Proteins 0.000 claims description 8
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 8
229910052802 copper Inorganic materials 0.000 claims description 8
239000010949 copper Substances 0.000 claims description 8
229960003067 cystine Drugs 0.000 claims description 8
YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 claims description 8
229930182817 methionine Natural products 0.000 claims description 8
YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 claims description 8
229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 6
239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 6
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 6
239000008112 carboxymethyl-cellulose Substances 0.000 claims description 6
125000000539 amino acid group Chemical group 0.000 claims description 5
239000001913 cellulose Substances 0.000 claims description 5
229920002678 cellulose Polymers 0.000 claims description 5
210000004962 mammalian cell Anatomy 0.000 claims description 4
239000012461 cellulose resin Substances 0.000 claims description 3
230000001590 oxidative effect Effects 0.000 claims description 3
210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 2
LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims 3
238000000746 purification Methods 0.000 abstract description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 50
108090000623 proteins and genes Proteins 0.000 description 42
102000004169 proteins and genes Human genes 0.000 description 35
235000018102 proteins Nutrition 0.000 description 33
235000001014 amino acid Nutrition 0.000 description 32
239000000243 solution Substances 0.000 description 27
239000011780 sodium chloride Substances 0.000 description 26
239000008363 phosphate buffer Substances 0.000 description 23
108020004414 DNA Proteins 0.000 description 21
239000013612 plasmid Substances 0.000 description 19
238000003752 polymerase chain reaction Methods 0.000 description 19
125000003275 alpha amino acid group Chemical group 0.000 description 15
108091034117 Oligonucleotide Proteins 0.000 description 14
239000002773 nucleotide Substances 0.000 description 12
125000003729 nucleotide group Chemical group 0.000 description 12
239000000047 product Substances 0.000 description 12
239000002299 complementary DNA Substances 0.000 description 11
239000012634 fragment Substances 0.000 description 11
241000588724 Escherichia coli Species 0.000 description 10
108091028043 Nucleic acid sequence Proteins 0.000 description 10
108020004707 nucleic acids Proteins 0.000 description 10
102000039446 nucleic acids Human genes 0.000 description 10
150000007523 nucleic acids Chemical class 0.000 description 10
239000002953 phosphate buffered saline Substances 0.000 description 10
108090000765 processed proteins & peptides Proteins 0.000 description 10
239000013598 vector Substances 0.000 description 9
239000000872 buffer Substances 0.000 description 8
239000000463 material Substances 0.000 description 8
238000006467 substitution reaction Methods 0.000 description 8
108020004705 Codon Proteins 0.000 description 7
238000002523 gelfiltration Methods 0.000 description 7
238000009396 hybridization Methods 0.000 description 7
230000003647 oxidation Effects 0.000 description 7
238000007254 oxidation reaction Methods 0.000 description 7
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
238000012408 PCR amplification Methods 0.000 description 6
229920002684 Sepharose Polymers 0.000 description 6
238000012217 deletion Methods 0.000 description 6
230000037430 deletion Effects 0.000 description 6
239000012528 membrane Substances 0.000 description 6
239000000203 mixture Substances 0.000 description 6
239000000523 sample Substances 0.000 description 6
241000283707 Capra Species 0.000 description 5
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 5
230000003321 amplification Effects 0.000 description 5
238000000137 annealing Methods 0.000 description 5
238000010367 cloning Methods 0.000 description 5
210000002950 fibroblast Anatomy 0.000 description 5
239000002609 medium Substances 0.000 description 5
238000012986 modification Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000003199 nucleic acid amplification method Methods 0.000 description 5
229920001184 polypeptide Polymers 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
102000004196 processed proteins & peptides Human genes 0.000 description 5
102000018233 Fibroblast Growth Factor Human genes 0.000 description 4
108050007372 Fibroblast Growth Factor Proteins 0.000 description 4
101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 description 4
102000003960 Ligases Human genes 0.000 description 4
108090000364 Ligases Proteins 0.000 description 4
239000000020 Nitrocellulose Substances 0.000 description 4
238000012300 Sequence Analysis Methods 0.000 description 4
230000027455 binding Effects 0.000 description 4
238000005352 clarification Methods 0.000 description 4
239000003636 conditioned culture medium Substances 0.000 description 4
235000018417 cysteine Nutrition 0.000 description 4
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
238000004925 denaturation Methods 0.000 description 4
230000036425 denaturation Effects 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
238000000855 fermentation Methods 0.000 description 4
230000004151 fermentation Effects 0.000 description 4
239000006166 lysate Substances 0.000 description 4
229920001220 nitrocellulos Polymers 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
239000001488 sodium phosphate Substances 0.000 description 4
229910000162 sodium phosphate Inorganic materials 0.000 description 4
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
238000005406 washing Methods 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
108010076504 Protein Sorting Signals Proteins 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
238000011210 chromatographic step Methods 0.000 description 3
238000010276 construction Methods 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
-1 fragments Chemical class 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000003993 interaction Effects 0.000 description 3
229930027917 kanamycin Natural products 0.000 description 3
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
229960000318 kanamycin Drugs 0.000 description 3
229930182823 kanamycin A Natural products 0.000 description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
238000001262 western blot Methods 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
208000002109 Argyria Diseases 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
108010031186 Glycoside Hydrolases Proteins 0.000 description 2
102000005744 Glycoside Hydrolases Human genes 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
101100446506 Mus musculus Fgf3 gene Proteins 0.000 description 2
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
241000700605 Viruses Species 0.000 description 2
239000008365 aqueous carrier Substances 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
108010029560 keratinocyte growth factor receptor Proteins 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000002297 mitogenic effect Effects 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
239000012465 retentate Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
125000003396 thiol group Chemical group [H]S* 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
238000012546 transfer Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
JEPVUMTVFPQKQE-AAKCMJRZSA-N 2-[(1s,2s,3r,4s)-1,2,3,4,5-pentahydroxypentyl]-1,3-thiazolidine-4-carboxylic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C1NC(C(O)=O)CS1 JEPVUMTVFPQKQE-AAKCMJRZSA-N 0.000 description 1
AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 1
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
RAAWHFXHAACDFT-FXQIFTODSA-N Ala-Met-Asn Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(O)=O RAAWHFXHAACDFT-FXQIFTODSA-N 0.000 description 1
VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 1
IIAXFBUTKIDDIP-ULQDDVLXSA-N Arg-Leu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IIAXFBUTKIDDIP-ULQDDVLXSA-N 0.000 description 1
XNSKSTRGQIPTSE-ACZMJKKPSA-N Arg-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O XNSKSTRGQIPTSE-ACZMJKKPSA-N 0.000 description 1
XRNXPIGJPQHCPC-RCWTZXSCSA-N Arg-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)O)C(O)=O XRNXPIGJPQHCPC-RCWTZXSCSA-N 0.000 description 1
ISVACHFCVRKIDG-SRVKXCTJSA-N Arg-Val-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O ISVACHFCVRKIDG-SRVKXCTJSA-N 0.000 description 1
KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 1
MJIJBEYEHBKTIM-BYULHYEWSA-N Asn-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N MJIJBEYEHBKTIM-BYULHYEWSA-N 0.000 description 1
ZRAOLTNMSCSCLN-ZLUOBGJFSA-N Asp-Cys-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)O ZRAOLTNMSCSCLN-ZLUOBGJFSA-N 0.000 description 1
UZFHNLYQWMGUHU-DCAQKATOSA-N Asp-Lys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZFHNLYQWMGUHU-DCAQKATOSA-N 0.000 description 1
SHBKFJNZNSGHDS-FGPLHTHASA-N Asp-Met-Thr-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O SHBKFJNZNSGHDS-FGPLHTHASA-N 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
KLLFLHBKSJAUMZ-ACZMJKKPSA-N Cys-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N KLLFLHBKSJAUMZ-ACZMJKKPSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
108090000380 Fibroblast growth factor 5 Proteins 0.000 description 1
102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
108090000382 Fibroblast growth factor 6 Proteins 0.000 description 1
102100028075 Fibroblast growth factor 6 Human genes 0.000 description 1
PBEQPAZRHDVJQI-SRVKXCTJSA-N Glu-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N PBEQPAZRHDVJQI-SRVKXCTJSA-N 0.000 description 1
SOEPMWQCTJITPZ-SRVKXCTJSA-N Glu-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N SOEPMWQCTJITPZ-SRVKXCTJSA-N 0.000 description 1
GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
NTOWAXLMQFKJPT-YUMQZZPRSA-N Gly-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN NTOWAXLMQFKJPT-YUMQZZPRSA-N 0.000 description 1
OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 1
OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
SVVULKPWDBIPCO-BZSNNMDCSA-N His-Phe-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O SVVULKPWDBIPCO-BZSNNMDCSA-N 0.000 description 1
SWBUZLFWGJETAO-KKUMJFAQSA-N His-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O SWBUZLFWGJETAO-KKUMJFAQSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
YVKSMSDXKMSIRX-GUBZILKMSA-N Leu-Glu-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YVKSMSDXKMSIRX-GUBZILKMSA-N 0.000 description 1
RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
239000006137 Luria-Bertani broth Substances 0.000 description 1
GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 1
HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 1
HAUUXTXKJNVIFY-ONGXEEELSA-N Lys-Gly-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAUUXTXKJNVIFY-ONGXEEELSA-N 0.000 description 1
UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 1
PLOUVAYOMTYJRG-JXUBOQSCSA-N Lys-Thr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PLOUVAYOMTYJRG-JXUBOQSCSA-N 0.000 description 1
YKBSXQFZWFXFIB-VOAKCMCISA-N Lys-Thr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O YKBSXQFZWFXFIB-VOAKCMCISA-N 0.000 description 1
HUKLXYYPZWPXCC-KZVJFYERSA-N Met-Ala-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HUKLXYYPZWPXCC-KZVJFYERSA-N 0.000 description 1
ADHNYKZHPOEULM-BQBZGAKWSA-N Met-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O ADHNYKZHPOEULM-BQBZGAKWSA-N 0.000 description 1
YORIKIDJCPKBON-YUMQZZPRSA-N Met-Glu-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YORIKIDJCPKBON-YUMQZZPRSA-N 0.000 description 1
PCTFVQATEGYHJU-FXQIFTODSA-N Met-Ser-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O PCTFVQATEGYHJU-FXQIFTODSA-N 0.000 description 1
101100446513 Mus musculus Fgf4 gene Proteins 0.000 description 1
102100030856 Myoglobin Human genes 0.000 description 1
108010062374 Myoglobin Proteins 0.000 description 1
YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
108010087066 N2-tryptophyllysine Proteins 0.000 description 1
108700015679 Nested Genes Proteins 0.000 description 1
102000005348 Neuraminidase Human genes 0.000 description 1
108010006232 Neuraminidase Proteins 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 1
108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
WLYPRKLMRIYGPP-JYJNAYRXSA-N Phe-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 WLYPRKLMRIYGPP-JYJNAYRXSA-N 0.000 description 1
ZYNBEWGJFXTBDU-ACRUOGEOSA-N Phe-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N ZYNBEWGJFXTBDU-ACRUOGEOSA-N 0.000 description 1
CDHURCQGUDNBMA-UBHSHLNASA-N Phe-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 CDHURCQGUDNBMA-UBHSHLNASA-N 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
AWJGUZSYVIVZGP-YUMQZZPRSA-N Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 AWJGUZSYVIVZGP-YUMQZZPRSA-N 0.000 description 1
241000219492 Quercus Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
CEXFELBFVHLYDZ-XGEHTFHBSA-N Thr-Arg-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CEXFELBFVHLYDZ-XGEHTFHBSA-N 0.000 description 1
LXXCHJKHJYRMIY-FQPOAREZSA-N Thr-Tyr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O LXXCHJKHJYRMIY-FQPOAREZSA-N 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
MPYZGXUYLNPSNF-NAZCDGGXSA-N Trp-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)O MPYZGXUYLNPSNF-NAZCDGGXSA-N 0.000 description 1
DVLHKUWLNKDINO-PMVMPFDFSA-N Trp-Tyr-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O DVLHKUWLNKDINO-PMVMPFDFSA-N 0.000 description 1
ONWMQORSVZYVNH-UWVGGRQHSA-N Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UWVGGRQHSA-N 0.000 description 1
TZXFLDNBYYGLKA-BZSNNMDCSA-N Tyr-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 TZXFLDNBYYGLKA-BZSNNMDCSA-N 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
101710201961 Virion infectivity factor Proteins 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
108010070944 alanylhistidine Proteins 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
108010080488 arginyl-arginyl-leucine Proteins 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
238000012925 biological evaluation Methods 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
238000005277 cation exchange chromatography Methods 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000013480 data collection Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
230000000368 destabilizing effect Effects 0.000 description 1
239000012470 diluted sample Substances 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
239000012636 effector Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000012149 elution buffer Substances 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
210000005175 epidermal keratinocyte Anatomy 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
230000008556 epithelial cell proliferation Effects 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
238000001400 expression cloning Methods 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
108010074605 gamma-Globulins Proteins 0.000 description 1
108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
125000000291 glutamic acid group Chemical class N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
150000002308 glutamine derivatives Chemical class 0.000 description 1
108010085617 glycopeptide alpha-N-acetylgalactosaminidase Proteins 0.000 description 1
108010089804 glycyl-threonine Proteins 0.000 description 1
108010015792 glycyllysine Proteins 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
239000012456 homogeneous solution Substances 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
102000057239 human FGF7 Human genes 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
230000035992 intercellular communication Effects 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
108010057821 leucylproline Proteins 0.000 description 1
238000009630 liquid culture Methods 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
108010064235 lysylglycine Proteins 0.000 description 1
108010054155 lysyllysine Proteins 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
108010056582 methionylglutamic acid Proteins 0.000 description 1
108010068488 methionylphenylalanine Proteins 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000003607 modifier Substances 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
238000007857 nested PCR Methods 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
108010070643 prolylglutamic acid Proteins 0.000 description 1
108010053725 prolylvaline Proteins 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229960001471 sodium selenite Drugs 0.000 description 1
235000015921 sodium selenite Nutrition 0.000 description 1
239000011781 sodium selenite Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
238000000844 transformation Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
208000016261 weight loss Diseases 0.000 description 1
239000013585 weight reducing agent Substances 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL14757595A 1994-10-13 1995-10-12 Method for purifying keratinocyte growth factors IL147575A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US32333994A	1994-10-13	1994-10-13
US08/487,830 US6008328A (en)	1994-10-13	1995-06-07	Method for purifying keratinocyte growth factors
IL11560595A IL115605A (en)	1994-10-13	1995-10-12	Method for purifying keratinocyte growth factors

Publications (1)

Publication Number	Publication Date
IL147575A true IL147575A (en)	2004-05-12

Family

ID=26983902

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL14757595A IL147575A (en)	1994-10-13	1995-10-12	Method for purifying keratinocyte growth factors
IL11560595A IL115605A (en)	1994-10-13	1995-10-12	Method for purifying keratinocyte growth factors
IL14757502A IL147575A0 (en)	1994-10-13	2002-01-10	Method for purifying keratinocyte growth factors

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL11560595A IL115605A (en)	1994-10-13	1995-10-12	Method for purifying keratinocyte growth factors
IL14757502A IL147575A0 (en)	1994-10-13	2002-01-10	Method for purifying keratinocyte growth factors

Country Status (18)

Country	Link
EP (2)	EP0785949B1 (fr)
JP (1)	JP3877226B2 (fr)
CN (1)	CN1161380C (fr)
AT (1)	ATE239038T1 (fr)
CA (1)	CA2201762C (fr)
CZ (1)	CZ98297A3 (fr)
DE (2)	DE122006000019I1 (fr)
DK (1)	DK0785949T3 (fr)
ES (1)	ES2197926T3 (fr)
HU (1)	HU220584B1 (fr)
IL (3)	IL147575A (fr)
LU (1)	LU91235I2 (fr)
NL (1)	NL300229I2 (fr)
NO (1)	NO971567L (fr)
PT (1)	PT785949E (fr)
SI (1)	SI0785949T1 (fr)
SK (1)	SK43097A3 (fr)
WO (1)	WO1996011952A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6077692A (en) *	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
AU1905799A (en)	1997-12-22	1999-07-12	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
JP2004526437A (ja) *	2001-02-06	2004-09-02	メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング	低減された免疫原性を有する修飾されたケラチノサイト成長因子（ｋｇｆ）
AU2002326742B2 (en) *	2001-08-21	2007-05-31	Novartis Vaccines And Diagnostics, Inc.	KGF polypeptide compositions
CN102242124B (zh) *	2010-05-10	2013-05-22	齐鲁制药有限公司	改造的角化细胞生长因子基因及其在酵母中的表达
CN102675449B (zh) *	2011-03-17	2016-06-08	重庆富进生物医药有限公司	缺失型人角质细胞生长因子-ⅰ二硫键变构体及其用途
CN109402130A (zh) *	2018-11-23	2019-03-01	成都中医药大学附属医院	一种重组人角质细胞生长因子-1及其制备方法和用途
CN110183529B (zh) *	2019-05-23	2023-06-02	重庆派金生物科技有限公司	一种缺失型人角质细胞生长因子-1的重组制备方法
KR20230127721A (ko)	2022-02-25	2023-09-01	한국해양과학기술원	온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990008771A1 (fr) *	1989-01-31	1990-08-09	Rubin Jeffrey S	Adn codant un facteur de croissance specifique contre des cellules epitheliales
WO1992011360A1 (fr) *	1990-12-18	1992-07-09	Amgen Inc.	Analogues du facteur de croissance acide des fibroblastes presentant une stabilite et une activite biologique ameliorees
DE69434053T2 (de) *	1993-06-29	2006-02-23	Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville	Verkürzter keratinocytenwachstumsfaktor(kgf)mit erhöhter biologischer aktivität
CA2172137C (fr) *	1993-09-24	1999-12-14	Andrew Peter Seddon	Analogues structurels de facteurs de croissance des fibroblastes, avec sequence en boucle
PT785950E (pt) *	1994-10-13	2003-09-30	Amgen Inc	Analogos do factor de crescimento de queratinocitos
EP0786000A1 (fr) *	1994-10-13	1997-07-30	Amgen Inc.	Analogues de facteur de croissance du fibroblaste acide a stabilite et activite biologique renforcees
KR100278597B1 (ko) *	1994-10-13	2001-01-15	스티븐 엠. 오드리	케라티노사이트 성장 인자의 유사체, 이 유사체를 암호하는 핵산 및 그것의 제조방법

1995
- 1995-10-12 CA CA002201762A patent/CA2201762C/fr not_active Expired - Lifetime
- 1995-10-12 DE DE1995630599 patent/DE122006000019I1/de active Pending
- 1995-10-12 CZ CZ97982A patent/CZ98297A3/cs unknown
- 1995-10-12 CN CNB951967959A patent/CN1161380C/zh not_active Expired - Lifetime
- 1995-10-12 DE DE69530599T patent/DE69530599T2/de not_active Expired - Lifetime
- 1995-10-12 AT AT95936309T patent/ATE239038T1/de active
- 1995-10-12 IL IL14757595A patent/IL147575A/en not_active IP Right Cessation
- 1995-10-12 SI SI9530657T patent/SI0785949T1/xx unknown
- 1995-10-12 DK DK95936309T patent/DK0785949T3/da active
- 1995-10-12 WO PCT/US1995/013099 patent/WO1996011952A1/fr not_active Ceased
- 1995-10-12 JP JP51337696A patent/JP3877226B2/ja not_active Expired - Lifetime
- 1995-10-12 HU HU9701514A patent/HU220584B1/hu unknown
- 1995-10-12 ES ES95936309T patent/ES2197926T3/es not_active Expired - Lifetime
- 1995-10-12 EP EP95936309A patent/EP0785949B1/fr not_active Expired - Lifetime
- 1995-10-12 IL IL11560595A patent/IL115605A/xx not_active IP Right Cessation
- 1995-10-12 PT PT95936309T patent/PT785949E/pt unknown
- 1995-10-12 EP EP02028624A patent/EP1334981B1/fr not_active Expired - Lifetime
- 1995-10-12 SK SK430-97A patent/SK43097A3/sk unknown
1997
- 1997-04-04 NO NO971567A patent/NO971567L/no unknown
2002
- 2002-01-10 IL IL14757502A patent/IL147575A0/xx active IP Right Grant
2006
- 2006-04-11 NL NL300229C patent/NL300229I2/nl unknown
- 2006-04-12 LU LU91235C patent/LU91235I2/fr unknown

Also Published As

Publication number	Publication date
NO971567L (no)	1997-06-12
DK0785949T3 (da)	2003-08-18
IL115605A (en)	2003-06-24
NO971567D0 (no)	1997-04-04
HU220584B1 (hu)	2002-03-28
IL115605A0 (en)	1996-01-19
PT785949E (pt)	2003-09-30
AU3830695A (en)	1996-05-06
DE69530599D1 (de)	2003-06-05
CN1169734A (zh)	1998-01-07
IL147575A0 (en)	2002-08-14
CZ98297A3 (cs)	1998-08-12
NL300229I2 (nl)	2006-09-01
WO1996011952A1 (fr)	1996-04-25
ATE239038T1 (de)	2003-05-15
CA2201762C (fr)	2001-12-18
EP1334981A2 (fr)	2003-08-13
NL300229I1 (nl)	2006-06-01
AU709362B2 (en)	1999-08-26
DE122006000019I1 (de)	2006-06-29
JP3877226B2 (ja)	2007-02-07
EP1334981A3 (fr)	2004-05-06
SI0785949T1 (en)	2003-08-31
LU91235I2 (fr)	2006-11-22
EP1334981B1 (fr)	2011-01-26
JPH10507452A (ja)	1998-07-21
EP0785949B1 (fr)	2003-05-02
DE69530599T2 (de)	2003-11-13
HUT76879A (en)	1997-12-29
CN1161380C (zh)	2004-08-11
SK43097A3 (en)	1998-10-07
EP0785949A1 (fr)	1997-07-30
MX9702481A (es)	1997-07-31
ES2197926T3 (es)	2004-01-16
CA2201762A1 (fr)	1996-04-25

Legal Events

Date	Code	Title
2006-01-15	KB	Patent renewed
2010-05-17	KB	Patent renewed
2011-12-29	EXTF	Application for patent extension filed
2014-05-28	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
KR100205078B1 (ko)	1999-06-15	염기성 섬유 아세포 성장인자 및 이의 생산방법
AU638402B2 (en)	1993-07-01	Analogs of fibroblast growth factor
US6074848A (en)	2000-06-13	Truncated keratinocyte growth factor (KGF) having increased biological activity
CA2202075C (fr)	2003-12-09	Analogues du facteur de croissance de keratinocytes, acides nucleiques encodant ces analogues, procede de fabrication et methodes d'utilisations
CA2201762C (fr)	2001-12-18	Procede pour purifier des facteurs de croissance des keratinocytes
CA1323317C (fr)	1993-10-19	Production de facteur de croissance de fibroblastes
US5705484A (en)	1998-01-06	Biologically active polypeptide fusion dimers
CA2202390C (fr)	2005-05-17	Analogues du facteur de croissance des keratinocytes
JP2002509691A (ja)	2002-04-02	生物学的活性が改変された組換えタンパク質多量体の製造及び使用
US6008328A (en)	1999-12-28	Method for purifying keratinocyte growth factors
IL88034A (en)	1994-06-24	Causes of a mutant acid fibroblast growth, its preparation and pharmaceutical preparations containing it
CA2485587C (fr)	2012-08-21	Muteines de facteur de croissance placentaire de type 1, leur procede de preparation et leur application
AU709362C (en)	2000-11-23	Method for purifying keratinocyte growth factors
US6103880A (en)	2000-08-15	HARP family growth factors
MXPA97002481A (en)	1997-12-01	Method for the purification of growth factors of queratinoci
AU745815B2 (en)	2002-04-11	Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
AU5068502A (en)	2002-08-08	Analogs of keratinocyte growth factor
MXPA97002475A (en)	1997-12-01	Analogues of the fibroblast acid growth factor that have stability and biological acticity improves